Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Medicare Experts

Analysis of: Patients Curb Prescription Spending (online.wsj.com)
if you think we are immune to downturns let me know why Congress just overrule the Bush Veto. They did it because providers were screaming due to the failed government run healthcare system and the downturn in economics of simply being able to get Paid.
Analysis of: While the U.S. Spends Heavily on Health Care, a Study Faults the Quality (www.nytimes.com)
Looking at the author of this piece it is clearly a statement for government run Healthcare. The person has only Univeral Healthcare on his agenda run by the government and has not heeded advice from those of us provide in the system as it is today. If his agenda wins out my Statement that I close my...
Richard Amerling, MD, Director of Outpatient Dialysis
Richard Amerling, MD, Director of Outpatient Dialysis
BETH ISRAEL MEDICAL CENTER INC
Analysis of: Pricey Drugs Put Squeeze on Doctors (online.wsj.com)
It's intresting that nowhere in this article was the topic of true insurance for catastrophic illness brought up.  The problem with our current health insurance market is that for most it is pre-paid care, not insurance against a rare, but catastrophic, event. 
Richard Amerling, MD, Director of Outpatient Dialysis
Richard Amerling, MD, Director of Outpatient Dialysis
BETH ISRAEL MEDICAL CENTER INC
Analysis of: 8-Year-Olds on Statins? A New Plan Quickly Bites Back (www.nytimes.com)
With the pipeline for new drugs running dry, it is no surprise that pharmaceutical companies are looking to expand indications for existing products still under patent protection.  What better way to do this than by creating entirely new patient populations out of whole cloth?
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: Time To Protect The Pharmaceutical Supply Chain (www.capitolweekly.net)
State Senator Mark Ridley-Thomas’ editorial argues California needs its own pharmaceutical supply chain security laws because the Federal government has failed to implement the Prescription Drug Marketing Act (PDMA). However, it does not necessarily follow that every individual state pharmacy board...
Analysis of: AMA meeting: Delegates decry CMS no-pay list as unrealistic and call for revision (www.ama-assn.org)
CMS (and several large insurers) refusing to pay for "Never Events" will further challenge cash strapped hospitals, and poses increased pressure to increase prices as hospitals attempt to cost-shift to the commercial carriers.  Not paying for alleged hospital mistakes will garner stronger administrative...
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: Pharmacies May Face More Than $110,000 Costs Per Store in First-Year to Implement Drug Track and Trace Technology if Mandated; Safety of Normal Distribution Channel Affirmed (www.nacds.org)
A new report from Accenture attempts to assess the financial costs of implementing a serialized track-and-trace system for the U.S. pharmacy supply chain. But even if we assume that Accenture did a credible and impartial job building their pharmacy cost models, the estimates in this report reflect an...
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: Acquired Stores Weigh on Rite Aid (online.wsj.com)
Perpetual also-ran Rite-Aid (RAD) reported another quarter of weak results. When Rite-Aid Brooks/Eckerd came together in August 2006, the deal seemed to make sense given the marketplace dynamics although none of the companies were as well run as CVS or Walgreens. However, the company’s ongoing struggles...
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: Walgreens prescribes more club card use (www.suntimes.com)
Walgreens (WAG) has begun touting its Walgreens Prescription Savings Club, which offers a 3-month supply of over 400 generics for $12.99 (plus an annual membership fee). Walgreens latest move suggests that the low-priced generic wave is having a bigger effect that many people (including me) expected....
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals (www.bio-medicine.org)
Baby boomers are rapidly aging. According to Census Bureau by 2010 there will be 77 million people aged 55 and older; a number which will grow to a whopping 98 million by 2020. This aging population, living longer with chronic illnesses and more demanding of cafeteria-type service will drive the demand...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 Next31 to 40 of 435

Analytics


Generated at 2009-01-07T19:00:58.307